SB649868

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

SB649868

Specification
Cat. No.
SMD1325
Related Diseases
Insomnia
Product Name
SB649868
Size
100.0mg; 200.0mg; 500.0mg; 1.0g; 2.0g
Price
Inquiry
Availability
2 Weeks
Description
SB649868, also known as GSK-649868, is an orexin receptor antagonist potentially for the treatment of insomnia and sleep disorder. SB-649868 promotes and maintains sleep in men with primary insomnia. SB-649868 may be a potentially effective and well-tolerated treatments for patients with sleep disorders.
CAS Number
380899-24-1
Chemical Formula
C26H24FN3O3S
Exact Mass
477.1522
Molecular Weight
477.5544
Elemental Analysis
C, 65.39; H, 5.07; F, 3.98; N, 8.80; O, 10.05; S, 6.71
Synonym
GSK-649868; GSK-649868; GSK649868; SB649868; SB-649868; SB 649868.
IUPAC/Chemical Name
(S)-N-((1-(5-(4-fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide
InChi Key
ZJXIUGNEAIHSBI-IBGZPJMESA-N
InChi Code
InChI=1S/C26H24FN3O3S/c1-16-29-23(24(34-16)17-8-10-18(27)11-9-17)26(32)30-13-3-2-5-19(30)15-28-25(31)21-6-4-7-22-20(21)12-14-33-22/h4,6-12,14,19H,2-3,5,13,15H2,1H3,(H,28,31)/t19-/m0/s1
SMILES Code
O=C(C1=C2C=COC2=CC=C1)NC[C@H]3N(C(C4=C(C5=CC=C(F)C=C5)SC(C)=N4)=O)CCCC3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top